1. Elevated serum vasohibin-1 levels in atopic dermatitis: Implications for disease chronicity.
- Author
-
Taira H, Ito Y, Yamamoto T, Koyama A, Li L, Sugimoto E, Mizuno Y, Awaji K, Sato S, and Shibata S
- Subjects
- Humans, Male, Female, Chronic Disease, Adult, Young Adult, Case-Control Studies, Neovascularization, Pathologic blood, Neovascularization, Pathologic metabolism, Adolescent, Endothelial Cells metabolism, Endothelial Cells pathology, Middle Aged, Dermatitis, Atopic blood, Dermatitis, Atopic pathology, Skin pathology, Skin metabolism, Skin blood supply, Vascular Endothelial Growth Factor A metabolism, Vascular Endothelial Growth Factor A blood, Vascular Endothelial Growth Factor A analysis, Cell Cycle Proteins metabolism, Cell Cycle Proteins analysis, Cell Cycle Proteins blood
- Abstract
Atopic dermatitis (AD) is often characterized by chronic skin changes of dermal fibrosis, typically regulated by inflammatory and angiogenic factors. However, the significance of angiogenesis inhibitory factors in the development of AD is poorly understood. The present study investigated the potential role of an angiogenesis inhibitory factor, vasohibin-1 (VASH1), in AD by evaluating serum and skin VASH1 levels and their correlation with clinical features. The results showed that VASH1 expression levels in both the serum and skin of patients with AD were significantly elevated compared to healthy controls. Immunohistochemical staining of AD skin showed increased VASH1 expression in dermal vascular endothelial cells. Notably, there was a significant correlation between serum VASH1 levels and disease duration as well as VASH1 and vascular endothelial growth factor A expression levels in the skin tissue of patients with AD. These results may suggest a pathogenesis of increased angiogenesis and associated elevated inhibitory processes accompanying inflammation in the chronic phase of AD., (© 2024 Japanese Dermatological Association.)
- Published
- 2024
- Full Text
- View/download PDF